These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 8738668
41. Influence of oral felodipine on serum cyclosporine concentrations. Cohen DJ, Teng SN, Appel GB. Clin Transplant; 1994 Dec; 8(6):541-5. PubMed ID: 7865916 [Abstract] [Full Text] [Related]
42. 24-hour blood pressure profile early after renal transplantation. Faria Mdo S, Nunes JP, Ferraz JM, Fernandes J, Praça A, Pestana M, Oliveira G, Guerra L, Polónia JJ. Rev Port Cardiol; 1995 Mar; 14(3):227-31. PubMed ID: 7766443 [Abstract] [Full Text] [Related]
43. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression. Chapman JR, Marcen R, Arias M, Raine AE, Dunnill MS, Morris PJ. Transplantation; 1987 Jun; 43(6):860-4. PubMed ID: 3296353 [Abstract] [Full Text] [Related]
44. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner RH, Krom RA. Transplantation; 1996 Dec 15; 62(11):1588-92. PubMed ID: 8970613 [Abstract] [Full Text] [Related]
45. [Effects of cyclosporin A on the diurnal variation of blood pressure in patients with nephrotic syndrome]. Takakuwa H, Yokoyama H, Yamamoto Y, Takasawa K, Ise T, Kobayashi K, Kawabata M, Takabatake T, Ohta H. Nihon Jinzo Gakkai Shi; 1997 May 15; 39(4):400-7. PubMed ID: 9198362 [Abstract] [Full Text] [Related]
46. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor. Sugiyama K, Tsukaguchi M, Toyama A, Satoh H, Saito K, Nakagawa Y, Takahashi K, Tanaka S, Onda K, Hirano T. Exp Clin Transplant; 2014 Jun 15; 12(3):195-9. PubMed ID: 24907718 [Abstract] [Full Text] [Related]
47. Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies). Vanrenterghem Y, Bresnahan B, Campistol J, Durrbach A, Grinyó J, Neumayer HH, Lang P, Larsen CP, Mancilla-Urrea E, Pestana JM, Block A, Duan T, Glicklich A, Gujrathi S, Vincenti F. Transplantation; 2011 May 15; 91(9):976-83. PubMed ID: 21372756 [Abstract] [Full Text] [Related]
48. Distal tubular acidosis induced by FK506. Heering P, Ivens K, Aker S, Grabensee B. Clin Transplant; 1998 Oct 15; 12(5):465-71. PubMed ID: 9787958 [Abstract] [Full Text] [Related]
49. A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants. Raofi V, Holman DM, Coady N, Vazquez E, Dunn TB, Bartholomew AM, Pollak R, Benedetti E. Am J Surg; 1999 Apr 15; 177(4):299-302. PubMed ID: 10326847 [Abstract] [Full Text] [Related]
50. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? Franz M, Regele H, Schmaldienst S, Stummvoll HK, Hörl WH, Pohanka E. Transplantation; 1998 Nov 15; 66(9):1258-62. PubMed ID: 9825827 [Abstract] [Full Text] [Related]
51. Cyclosporine: an immunosuppressive panacea? Copeland JG, Emery RW, Levinson MM, Icenogle TB, Riley JE, McAleer MJ, Copeland JA, Dietz R. J Thorac Cardiovasc Surg; 1986 Jan 15; 91(1):26-39. PubMed ID: 3079849 [Abstract] [Full Text] [Related]
52. Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial. Moes AD, Hesselink DA, van den Meiracker AH, Zietse R, Hoorn EJ. Am J Kidney Dis; 2017 Jun 15; 69(6):796-804. PubMed ID: 28259499 [Abstract] [Full Text] [Related]
53. Renal sodium transporters are increased in urinary exosomes of cyclosporine-treated kidney transplant patients. Esteva-Font C, Guillén-Gómez E, Diaz JM, Guirado L, Facundo C, Ars E, Ballarin JA, Fernández-Llama P. Am J Nephrol; 2014 Jun 15; 39(6):528-35. PubMed ID: 24942911 [Abstract] [Full Text] [Related]
54. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Textor SC, Wiesner R, Wilson DJ, Porayko M, Romero JC, Burnett JC, Gores G, Hay E, Dickson ER, Krom RA. Transplantation; 1993 Jun 15; 55(6):1332-9. PubMed ID: 7685934 [Abstract] [Full Text] [Related]
55. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA. Schmidt A, Gruber U, Böhmig G, Köller E, Mayer G. Nephrol Dial Transplant; 2001 May 15; 16(5):1034-7. PubMed ID: 11328912 [Abstract] [Full Text] [Related]
56. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. Rostaing L, Puyoo O, Tkaczuk J, Peres C, Rouzaud A, Cisterne JM, de Preval C, Ohayon E, Durand D, Abbal M. Clin Transplant; 1999 Oct 15; 13(5):400-9. PubMed ID: 10515221 [Abstract] [Full Text] [Related]
57. Renal function and blood pressure in heart transplant recipients treated with cyclosporine. Rottembourg J, Mattei MF, Cabrol A, Leger P, Aupetit B, Beaufils H, Gluckman JC, Pavie A, Gandjbakhch I, Cabrol C. J Heart Transplant; 1985 Oct 15; 4(4):404-8. PubMed ID: 3916515 [Abstract] [Full Text] [Related]
58. Differential effects of cyclosporine and tacrolimus on arterial function. Seibert F, Behrendt C, Schmidt S, van der Giet M, Zidek W, Westhoff TH. Transpl Int; 2011 Jul 15; 24(7):708-15. PubMed ID: 21569126 [Abstract] [Full Text] [Related]